Naomi Kitayama

Naomi Kitayama

Auto-generated profile, based on publicly available information

Naomi Kitayama

Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Endocrine Journal
Verified
Journal Article
Open access
PDF file
Kenichi KakudoKenichi Kakudo
Kenichi Kakudo
ZLZhiyan Liu
Zhiyan Liu
YBYanhua Bai
Yanhua Bai
YLYaqiong Li
Yaqiong Li
NKNaomi Kitayama
Naomi Kitayama
Chan Kwon JungChan Kwon Jung
Chan Kwon Jung
Current histopathological diagnosis methods cannot distinguish the two types of thyroid carcinoma: clinically significant carcinomas with a potential risk of recurrence, metastasis, and cancer death, and clinically insignificant carcinomas with a slow growth rate. Both thyroid tumors are diagnosed as “carcinoma” in current pathology practice. The clinician usually recommends surgery to the patient and the patient often accepts it because of cancer terminology. The treatment for these clinically insignificant carcinomas does not benefit the patient and negatively impacts society. The author proposed risk stratification of thyroid tumors using the growth rate (Ki-67 labeling index), which accurately differentiates four prognostically relevant risk groups based on the Ki-67 labeling index, ≥30%, ≥10 and 5 and <10%, and ≤5%. Indolent thyroid tumors with an excellent prognosis have the following four features: young age, early-stage (T1-2 M0), curatively treated, and low proliferation index (Ki-67 labeling index of ≤5%), and are unlikely to recur, metastasize, or cause cancer death. Accurate identification of these indolent tumors helps clinicians select more conservative treatments to avoid unnecessary aggressive (total thyroidectomy followed by radio-active iodine) treatments. Clinicians can alleviate the fears of patients by confirming these four features, including the low proliferation rate, in a pathology report immediately after surgery when patients are most concerned.

3 September 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NKNaomi Kitayama
Naomi Kitayama
CNChisa Nakashima
Chisa Nakashima
TSTeruo Sawada
Teruo Sawada
NTNobuo Tanaka
Nobuo Tanaka
MHMasatoshi Hagiwara
Masatoshi Hagiwara
KKKenji Kabashima
Kenji Kabashima

13 February 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
HIHiroyuki Irie
Hiroyuki Irie
CNChisa Nakashima
Chisa Nakashima
YIYoshihiro Ishida
Yoshihiro Ishida
NKNaomi Kitayama
Naomi Kitayama
MHMasahiro Hirata
Masahiro Hirata
KKKenji Kabashima
Kenji Kabashima

24 August 2017 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
NKNaomi Kitayama
Naomi Kitayama
SNSatoshi Nakamizo
Satoshi Nakamizo
YNYumi Nonomura
Yumi Nonomura
YKYo Kaku
Yo Kaku
YEYuichiro Endo
Yuichiro Endo
KKKenji Kabashima
Kenji Kabashima